Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages

ABSTRACT Escherichia coli sequence type 131 (ST131), a pandemic clone responsible for the high incidence of extraintestinal pathogenic E. coli (ExPEC) infections, has been known widely for its contribution to the worldwide dissemination of multidrug resistance. Although other ExPEC-associated and ex...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sabiha Shaik, Amit Ranjan, Sumeet K. Tiwari, Arif Hussain, Nishant Nandanwar, Narender Kumar, Savita Jadhav, Torsten Semmler, Ramani Baddam, Mohammed Aminul Islam, Munirul Alam, Lothar H. Wieler, Haruo Watanabe, Niyaz Ahmed
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://doaj.org/article/45493efb8ca9421cb6cf9ea5b4ae5b0c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:45493efb8ca9421cb6cf9ea5b4ae5b0c
record_format dspace
spelling oai:doaj.org-article:45493efb8ca9421cb6cf9ea5b4ae5b0c2021-11-15T15:51:51ZComparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages10.1128/mBio.01596-172150-7511https://doaj.org/article/45493efb8ca9421cb6cf9ea5b4ae5b0c2017-11-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01596-17https://doaj.org/toc/2150-7511ABSTRACT Escherichia coli sequence type 131 (ST131), a pandemic clone responsible for the high incidence of extraintestinal pathogenic E. coli (ExPEC) infections, has been known widely for its contribution to the worldwide dissemination of multidrug resistance. Although other ExPEC-associated and extended-spectrum-β-lactamase (ESBL)-producing E. coli clones, such as ST38, ST405, and ST648 have been studied widely, no comparative genomic data with respect to other genotypes exist for ST131. In this study, comparative genomic analysis was performed for 99 ST131 E. coli strains with 40 genomes from three other STs, including ST38 (n = 12), ST405 (n = 10), and ST648 (n = 18), and functional studies were performed on five in-house strains corresponding to the four STs. Phylogenomic analysis results from this study corroborated with the sequence type-specific clonality. Results from the genome-wide resistance profiling confirmed that all strains were inherently multidrug resistant. ST131 genomes showed unique virulence profiles, and analysis of mobile genetic elements and their associated methyltransferases (MTases) has revealed that several of them were missing from the majority of the non-ST131 strains. Despite the fact that non-ST131 strains lacked few essential genes belonging to the serum resistome, the in-house strains representing all four STs demonstrated similar resistance levels to serum antibactericidal activity. Core genome analysis data revealed that non-ST131 strains usually lacked several ST131-defined genomic coordinates, and a significant number of genes were missing from the core of the ST131 genomes. Data from this study reinforce adaptive diversification of E. coli strains belonging to the ST131 lineage and provide new insights into the molecular mechanisms underlying clonal diversification of the ST131 lineage. IMPORTANCE E. coli, particularly the ST131 extraintestinal pathogenic E. coli (ExPEC) lineage, is an important cause of community- and hospital-acquired infections, such as urinary tract infections, surgical site infections, bloodstream infections, and sepsis. The treatment of infections caused by ExPEC has become very challenging due to the emergence of resistance to the first-line as well as the last-resort antibiotics. This study analyzes E. coli ST131 against three other important and globally distributed ExPEC lineages (ST38, ST405, and ST648) that also produced extended-spectrum β-lactamase (ESBL). This is perhaps the first study that employs the high-throughput whole-genome sequence-based approach to compare and study the genomic features of these four ExPEC lineages in relation to their functional properties. Findings from this study highlight the differences in the genomic coordinates of ST131 with respect to the other STs considered here. Results from this comparative genomics study can help in advancing the understanding of ST131 evolution and also offer a framework towards future developments in pathogen identification and targeted therapeutics to prevent diseases caused by this pandemic E. coli ST131 clone.Sabiha ShaikAmit RanjanSumeet K. TiwariArif HussainNishant NandanwarNarender KumarSavita JadhavTorsten SemmlerRamani BaddamMohammed Aminul IslamMunirul AlamLothar H. WielerHaruo WatanabeNiyaz AhmedAmerican Society for Microbiologyarticlebacterial evolutionEscherichia coligenomicsST131 lineagemolecular epidemiologyMicrobiologyQR1-502ENmBio, Vol 8, Iss 5 (2017)
institution DOAJ
collection DOAJ
language EN
topic bacterial evolution
Escherichia coli
genomics
ST131 lineage
molecular epidemiology
Microbiology
QR1-502
spellingShingle bacterial evolution
Escherichia coli
genomics
ST131 lineage
molecular epidemiology
Microbiology
QR1-502
Sabiha Shaik
Amit Ranjan
Sumeet K. Tiwari
Arif Hussain
Nishant Nandanwar
Narender Kumar
Savita Jadhav
Torsten Semmler
Ramani Baddam
Mohammed Aminul Islam
Munirul Alam
Lothar H. Wieler
Haruo Watanabe
Niyaz Ahmed
Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages
description ABSTRACT Escherichia coli sequence type 131 (ST131), a pandemic clone responsible for the high incidence of extraintestinal pathogenic E. coli (ExPEC) infections, has been known widely for its contribution to the worldwide dissemination of multidrug resistance. Although other ExPEC-associated and extended-spectrum-β-lactamase (ESBL)-producing E. coli clones, such as ST38, ST405, and ST648 have been studied widely, no comparative genomic data with respect to other genotypes exist for ST131. In this study, comparative genomic analysis was performed for 99 ST131 E. coli strains with 40 genomes from three other STs, including ST38 (n = 12), ST405 (n = 10), and ST648 (n = 18), and functional studies were performed on five in-house strains corresponding to the four STs. Phylogenomic analysis results from this study corroborated with the sequence type-specific clonality. Results from the genome-wide resistance profiling confirmed that all strains were inherently multidrug resistant. ST131 genomes showed unique virulence profiles, and analysis of mobile genetic elements and their associated methyltransferases (MTases) has revealed that several of them were missing from the majority of the non-ST131 strains. Despite the fact that non-ST131 strains lacked few essential genes belonging to the serum resistome, the in-house strains representing all four STs demonstrated similar resistance levels to serum antibactericidal activity. Core genome analysis data revealed that non-ST131 strains usually lacked several ST131-defined genomic coordinates, and a significant number of genes were missing from the core of the ST131 genomes. Data from this study reinforce adaptive diversification of E. coli strains belonging to the ST131 lineage and provide new insights into the molecular mechanisms underlying clonal diversification of the ST131 lineage. IMPORTANCE E. coli, particularly the ST131 extraintestinal pathogenic E. coli (ExPEC) lineage, is an important cause of community- and hospital-acquired infections, such as urinary tract infections, surgical site infections, bloodstream infections, and sepsis. The treatment of infections caused by ExPEC has become very challenging due to the emergence of resistance to the first-line as well as the last-resort antibiotics. This study analyzes E. coli ST131 against three other important and globally distributed ExPEC lineages (ST38, ST405, and ST648) that also produced extended-spectrum β-lactamase (ESBL). This is perhaps the first study that employs the high-throughput whole-genome sequence-based approach to compare and study the genomic features of these four ExPEC lineages in relation to their functional properties. Findings from this study highlight the differences in the genomic coordinates of ST131 with respect to the other STs considered here. Results from this comparative genomics study can help in advancing the understanding of ST131 evolution and also offer a framework towards future developments in pathogen identification and targeted therapeutics to prevent diseases caused by this pandemic E. coli ST131 clone.
format article
author Sabiha Shaik
Amit Ranjan
Sumeet K. Tiwari
Arif Hussain
Nishant Nandanwar
Narender Kumar
Savita Jadhav
Torsten Semmler
Ramani Baddam
Mohammed Aminul Islam
Munirul Alam
Lothar H. Wieler
Haruo Watanabe
Niyaz Ahmed
author_facet Sabiha Shaik
Amit Ranjan
Sumeet K. Tiwari
Arif Hussain
Nishant Nandanwar
Narender Kumar
Savita Jadhav
Torsten Semmler
Ramani Baddam
Mohammed Aminul Islam
Munirul Alam
Lothar H. Wieler
Haruo Watanabe
Niyaz Ahmed
author_sort Sabiha Shaik
title Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages
title_short Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages
title_full Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages
title_fullStr Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages
title_full_unstemmed Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages
title_sort comparative genomic analysis of globally dominant st131 clone with other epidemiologically successful extraintestinal pathogenic <italic toggle="yes">escherichia coli</italic> (expec) lineages
publisher American Society for Microbiology
publishDate 2017
url https://doaj.org/article/45493efb8ca9421cb6cf9ea5b4ae5b0c
work_keys_str_mv AT sabihashaik comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT amitranjan comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT sumeetktiwari comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT arifhussain comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT nishantnandanwar comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT narenderkumar comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT savitajadhav comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT torstensemmler comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT ramanibaddam comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT mohammedaminulislam comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT munirulalam comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT lotharhwieler comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT haruowatanabe comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
AT niyazahmed comparativegenomicanalysisofgloballydominantst131clonewithotherepidemiologicallysuccessfulextraintestinalpathogenicitalictoggleyesescherichiacoliitalicexpeclineages
_version_ 1718427330451341312